Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qun Luo

Showing results (621-630 of 636) with videos related to

Pageof 64
Sort By:
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Respirology (Carlton, Vic.)|April 15, 2026
Upadacitinib Versus Tofacitinib in Anti-MDA5-Positive Dermatomyositis With Interstitial Lung Disease: A Multi-Centre Cohort Study Emulating a Target TrialCan Xia, Wanlong Wu, Saisai Lu, et al.
The European Respiratory Journal|January 30, 2025
Effectiveness and safety of tofacitinib <i>versus</i> calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort studyWanlong Wu, Bingpeng Guo, Wenjia Sun, et al.
Nature Communications|March 21, 2026
Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosisLanlan Zhang, Xuezhen Gui, Ruijie Hou, et al.
Eclinicalmedicine|December 8, 2025
Landscape of paediatric oncology clinical trials in AsiaMuhammad Saghir Khan, Daisuke Tomizawa, Huyung Zheng, et al.
Blood Cancer Journal|December 5, 2023
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL groupDan-Ping Huang, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|April 15, 2022
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyYun-Yan He, Xiao-Jing Wu, Dun-Hua Zhou, et al.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
American Journal of Nephrology|March 12, 2026
The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (recombinant human erythropoietin), Open-Label Study：the ENARODIAL studyHaishan Wu, Zhen Ai, Aiying Liu, et al.
Pageof 64

Showing results (621-630 of 636) with videos related to

Sort By:
Pageof 64
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Respirology (Carlton, Vic.)|April 15, 2026
Upadacitinib Versus Tofacitinib in Anti-MDA5-Positive Dermatomyositis With Interstitial Lung Disease: A Multi-Centre Cohort Study Emulating a Target TrialCan Xia, Wanlong Wu, Saisai Lu, et al.
The European Respiratory Journal|January 30, 2025
Effectiveness and safety of tofacitinib <i>versus</i> calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort studyWanlong Wu, Bingpeng Guo, Wenjia Sun, et al.
Nature Communications|March 21, 2026
Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosisLanlan Zhang, Xuezhen Gui, Ruijie Hou, et al.
Eclinicalmedicine|December 8, 2025
Landscape of paediatric oncology clinical trials in AsiaMuhammad Saghir Khan, Daisuke Tomizawa, Huyung Zheng, et al.
Blood Cancer Journal|December 5, 2023
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL groupDan-Ping Huang, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|April 15, 2022
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyYun-Yan He, Xiao-Jing Wu, Dun-Hua Zhou, et al.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
American Journal of Nephrology|March 12, 2026
The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (recombinant human erythropoietin), Open-Label Study：the ENARODIAL studyHaishan Wu, Zhen Ai, Aiying Liu, et al.
Pageof 64